Growth Metrics

Elanco Animal Health (ELAN) Cash & Current Investments (2017 - 2026)

Elanco Animal Health's Cash & Current Investments history spans 9 years, with the latest figure at $545.0 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 16.45% to $545.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $545.0 million, a 16.45% increase, with the full-year FY2025 number at $545.0 million, up 16.45% from a year prior.
  • Cash & Current Investments hit $545.0 million in Q4 2025 for Elanco Animal Health, up from $505.0 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for ELAN hit a ceiling of $638.0 million in Q4 2021 and a floor of $318.0 million in Q1 2023.
  • Historically, Cash & Current Investments has averaged $452.0 million across 5 years, with a median of $464.0 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: crashed 58.63% in 2021 and later skyrocketed 41.16% in 2025.
  • Tracing ELAN's Cash & Current Investments over 5 years: stood at $638.0 million in 2021, then plummeted by 45.92% to $345.0 million in 2022, then grew by 2.03% to $352.0 million in 2023, then skyrocketed by 32.95% to $468.0 million in 2024, then increased by 16.45% to $545.0 million in 2025.
  • Business Quant data shows Cash & Current Investments for ELAN at $545.0 million in Q4 2025, $505.0 million in Q3 2025, and $539.0 million in Q2 2025.